Clinical Trial Update: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating two-dose regimens of GlaxoSmithKline varicella vaccines in healthy children aged 12-23 months; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chickenpox
• Varicella

Drugs mentioned

• varicella vaccines (GlaxoSmithKline two-dose regimens)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chicken-pox Illness (Varicella Virus Disease), Chickenpox | Phase 3 | Status: COMPLETED | Results posted: 2017-10-11